Celldex Therapeutics buy Wells Fargo & Company
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€32.67
Performance (%)
65.60%
Price
22.07.26
?
Summary
This prediction is currently active. With a performance of 65.60% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -8.863% | -8.863% |
| iShares Core DAX® | 0,07 % | 0,24 % |
| iShares Nasdaq 100 | -1,34 % | -3,37 % |
| iShares Nikkei 225® | -2,31 % | -7,50 % |
| iShares S&P 500 | -0,34 % | 0,90 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€42.08
22.07.27
22.07.27
0.00%
22.07.26
22.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.84
13.05.26
13.05.26
€46.01
13.05.27
13.05.27
9.45%
22.07.26
22.07.26